These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6147810)

  • 21. Hereditary tyrosinemia type I--an overview.
    Kvittingen EA
    Scand J Clin Lab Invest Suppl; 1986; 184():27-34. PubMed ID: 3296130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine aminotransferase deficiency in mink (Mustela vision): a model for human tyrosinemia II.
    Goldsmith LA; Thorpe JM; Marsh RF
    Biochem Genet; 1981 Aug; 19(7-8):687-93. PubMed ID: 6117279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parahydroxyphenylpyruvicacidemia in tyrosinosis.
    Jaiswal RB; Bhai I; Daginawala HF; Nath N; Nath MC
    Indian Pediatr; 1978 Nov; 15(11):893-9. PubMed ID: 36347
    [No Abstract]   [Full Text] [Related]  

  • 24. The pre- and post-natal diagnosis of tyrosinemia type I and the detection of the carrier state by assay of fumarylacetoacetase.
    Kvittingen EA; Brodtkorb E
    Scand J Clin Lab Invest Suppl; 1986; 184():35-40. PubMed ID: 3473612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Four-hydroxyphenylpyruvic acid oxidase deficiency with normal fumarylacetoacetase: a new variant form of hereditary hypertyrosinemia.
    Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
    Pediatr Res; 1983 Feb; 17(2):92-6. PubMed ID: 6828337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inherited and de novo deletion of the tyrosine aminotransferase gene locus at 16q22.1----q22.3 in a patient with tyrosinemia type II.
    Natt E; Westphal EM; Toth-Fejel SE; Magenis RE; Buist NR; Rettenmeier R; Scherer G
    Hum Genet; 1987 Dec; 77(4):352-8. PubMed ID: 2891604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypertyrosinemia].
    Kitagawa T
    Nihon Rinsho; 1978 May; Suppl():1340-1. PubMed ID: 29146
    [No Abstract]   [Full Text] [Related]  

  • 28. Tyrosinemia without liver or renal damage with plantar and palmar keratosis and keratitis (hypertyrosinemia type II).
    Pelet B; Antener I; Faggioni R; Spahr A; Gautier E
    Helv Paediatr Acta; 1979 May; 34(2):177-83. PubMed ID: 156708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Richner-Hanhart syndrome (tyrosinemia type II). Case report and literature review.
    al-Hemidan AI; al-Hazzaa SA
    Ophthalmic Genet; 1995 Mar; 16(1):21-6. PubMed ID: 7648039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tyrosinemia II.
    Goldsmith LA
    Int J Dermatol; 1985 Jun; 24(5):293-4. PubMed ID: 2862113
    [No Abstract]   [Full Text] [Related]  

  • 31. Dietary treatment of tyrosinemia type I: importance of methionine restriction.
    Michals K; Matolon R; Wong PW
    J Am Diet Assoc; 1978 Nov; 73(5):507-14. PubMed ID: 701680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome).
    Goldsmith LA
    Exp Cell Biol; 1978; 46(1-2):96-113. PubMed ID: 23331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of a low-protein diet and dietary supplementation of threonine on tyrosine and 2-(2-nitro-4-trifluoromethylbenzoyl) cyclohexane-1,3-dione-induced corneal lesions, the extent of tyrosinemia, and the activity of enzymes involved in tyrosine catabolism in the rat.
    Lock EA; Gaskin P; Ellis MK; Robinson M; Provan WM; Smith LL
    Toxicol Appl Pharmacol; 1998 May; 150(1):125-32. PubMed ID: 9630461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different clinical forms of hereditary tyrosinemia (type I) in patients with identical genotypes.
    Poudrier J; Lettre F; Scriver CR; Larochelle J; Tanguay RM
    Mol Genet Metab; 1998 Jun; 64(2):119-25. PubMed ID: 9705236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary tyrosinemia type I: lack of correlation between clinical findings and amount of immunoreactive fumarylacetoacetase protein.
    Kvittingen EA; Rootwelt H; van Dam T; van Faassen H; Berger R
    Pediatr Res; 1992 Jan; 31(1):43-6. PubMed ID: 1594329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The genetic tyrosinemias.
    Scott CR
    Am J Med Genet C Semin Med Genet; 2006 May; 142C(2):121-6. PubMed ID: 16602095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Juvenile form of tyrosinemia type I].
    Nothjunge J; Rosendahl W
    Klin Padiatr; 1989; 201(6):458-63. PubMed ID: 2601281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New forms of hereditary tyrosinemia type II in mink: hepatic tyrosine aminotransferase defect.
    Christensen K; Henriksen P; Sørensen H
    Hereditas; 1986; 104(2):215-22. PubMed ID: 2876972
    [No Abstract]   [Full Text] [Related]  

  • 39. Tyrosinemia II: lessons in molecular pathophysiology.
    Goldsmith LA
    Pediatr Dermatol; 1983 Jul; 1(1):25-34. PubMed ID: 6149527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tyrosinemia].
    Salo MK
    Duodecim; 1992; 108(9):841-3. PubMed ID: 1366298
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.